BURON NUTRASCIENCE CORP - BRCNF STOCK NEWS

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) and HPS Food and Ingredients Inc. will be showcasing their high-purity 95% hempseed protein isolate at the upcoming SupplySide West show in Las Vegas, NV, from October 30th - 31st. The companies aim to highlight the taste, color, and functional benefits of this new-to-the-world protein ingredient.

Kip Underwood, Burcon's CEO, emphasized that their hempseed protein outperforms competing products and enables the creation of clean-label, sustainable, and delicious food and beverage products. Burcon and HPS report building a strong customer funnel for the isolate, which has received positive feedback. Commercial samples are available, and interested parties can visit HPS at Booth #1841 during the show or contact their sales team directly for more information.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has launched its Puratein® canola protein for the egg replacement market. This product offers food manufacturers a sustainable and cost-effective alternative to eggs, particularly for use in baked goods. The launch comes amid surging egg prices due to supply challenges and avian influenza outbreaks.

Burcon's canola protein isolate, with over 90% protein purity, has demonstrated the ability to replace up to 100% of powdered and shelled eggs, delivering cost-in-use savings of 20-30%. The product not only provides superior functionality and price stability but also offers a vegan-friendly option for consumers. This development opens up new possibilities for creating superior, more sustainable plant-based alternatives in the food industry.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed the process validation phase of a contract research project for a leading industry peer. This achievement showcases Burcon's technical capabilities and expertise in plant-based proteins. The project, which involved validating a food ingredient process, is now ready for scale-up.

Kip Underwood, Burcon's CEO, emphasized that collaboration is part of their market engagement strategy and creates new business opportunities. Randy Willardsen, Senior VP of Process, expressed readiness for further collaborations in the plant-based protein market.

Burcon continues to leverage its expertise through contract services, with additional projects in the pipeline. The company offers innovative processing solutions to companies looking to innovate and scale in the alternative protein market.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) held its 2024 annual general and special meeting on September 18, 2024. All eight nominees proposed for the board of directors were elected. Shareholders approved the appointment of KPMG LLP as auditors, the warrants issued to John A. Vassallo, and authorized the board to effect a potential share consolidation.

James Pekar, with over 30 years of experience in the dairy and food industry, was elected as a new director. Pekar founded First Choice Ingredients, which he sold to DSM for US$460 million in 2021. He currently holds approximately 2.2% of Burcon's outstanding common shares. Dr. Lorne Tyrrell retired from the board and did not stand for re-election.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a leader in plant-based protein development, announces CEO Kip Underwood's participation in the Protein Industries Canada Annual Conference on September 11, 2024. Underwood will be a panelist in the session 'Driving Innovative IP in Canada's Competitive Landscape,' discussing topics such as capturing innovation value, fostering legal clarity in collaboration, and expanding beyond Canadian borders.

The conference, themed 'Progress and Prosperity,' brings together industry leaders and innovators to share insights on the future of value-added agriculture. Underwood emphasizes the importance of intellectual property as the foundation of Burcon's innovative protein technologies, highlighting the company's commitment to advancing the plant-based protein industry.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein development, has announced details for its upcoming virtual Annual General and Special Meeting (AGM) scheduled for September 18, 2024, at 10:00 am Pacific Time. Shareholders can attend the AGM and view the company's presentation via a provided webcast link.

The company has mailed out Meeting Materials, including the Notice of Meeting, Management Proxy Circular, and Form of Proxy, on or around August 12, 2024. Shareholders are encouraged to vote in advance by 10:00 am Pacific Time on September 16, 2024. Only registered shareholders and appointed proxyholders can vote during the AGM. Shareholders can submit questions in advance to plam@burcon.ca, which will be addressed during CEO Kip Underwood's presentation.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed a commercial production campaign for its premium hemp and canola protein isolates. The company has refined its process to ensure exceptional purity, flavor, and functionality while maintaining consistent quality. Burcon's proteins are expected to play a key role in helping companies bring great-tasting, healthy plant-based foods to market.

Burcon's offerings include a 95% Hempseed Protein Isolate, ideal for beverages, dairy alternatives, protein bars, and nutritional supplements, and Puratein® C Canola Protein Isolate, which is nutritionally complete with a Protein Digestibility-Corrected Amino Acid Score of 1. Puratein® C is highly soluble across a broad pH range, suitable for various applications including egg protein replacement.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) reported results for the fiscal first quarter ended June 30, 2024. The company achieved its first commercial protein sale, marking a significant milestone. Burcon launched a high purity, nutritionally complete canola protein and expanded US investor outreach by trading shares on the OTCQB Venture Market. The company reported revenues of $0.2 million from hemp protein isolate sales and contract research services, compared to no revenues in the same period last year. Burcon reported a net loss of $1.9 million or $0.01 per share, unchanged from the previous year. Cash balances totaled $2.2 million as of June 30, 2024, down from $4.2 million on March 31, 2024.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a leader in plant-based protein development, has announced its fiscal 2025 first quarter conference call scheduled for August 14, 2024, at 5:00 p.m. Eastern time. The company will discuss financial results for the quarter ended June 30, 2024, which will be released prior to the call.

CEO Kip Underwood expressed optimism about Burcon's transition from a technology creator to a profit-generating innovator. The company is focusing on executing a capital-light strategy and bringing its plant-based protein ingredients to market. Investors can participate in the live call or access the webcast through Burcon's website.